Sheri Tallman-Bretherton

Sheri Tallman-Bretherton has a strong background in clinical research, with experience at various companies. Sheri is currently serving as the Director of Clinical Research and Operations at Macro Trials since December 2022. Prior to this, they worked as a Clinical Research Consultant at Genentech starting in February 2020. From May 2022 to December 2022, they served as a Clinical Research Associate II at PPD, and from May 2021 to May 2022, they held the position of Clinical Research Associate at the same company. Sheri has also worked at The Retina Partners as the Director of Clinical Research from February 2018 to May 2021. Prior to that, they worked at Retina Specialty Institute as a Senior Clinical Research Coordinator and Scribe from February 2010 until an unspecified date in 2018. At both of these roles, Sheri conducted clinical trials in accordance with FDA regulations and guidelines, as well as ICH/GCP compliance, and was responsible for protocol reviews, budgeting, and regulatory document submissions.

Sheri Tallman-Bretherton's education history includes attending Utah Valley University and Leon. However, no specific information regarding degree names or fields of study is provided, and the start and end years are also unknown.